Skip to main content
. 2022 Oct 4;52(1):13–36. doi: 10.1016/j.gtc.2022.09.001

Fig. 2.

Fig. 2

Mortality in patients with COVID-19 infection in chronic liver disease, cirrhosis (Child-Turcotte-Pugh classes A, B, and C) and liver-transplant recipients, and stepwise increment of mortality in patients with chronic liver disease and cirrhosis following hospitalization, admission to ICU and invasive ventilation.

(Data from Marjot T, Moon AM, Cook JA, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. Journal of hepatology. 2021;74(3):567-577; and Webb GJ, Marjot T, Cook JA, et al. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. The Lancet Gastroenterology & Hepatology. 2020;5(11):1008-1016.)